Analysis and management of coronary heart disease complicated by thrombocytopenia
10.3969/j.issn.1006-0111.201906105
- VernacularTitle:冠心病合并血小板减少的分析与处理策略
- Author:
Xingxia LI
1
;
Yan HUO
1
;
Xipeng SUN
1
;
Yan CHEN
1
;
Yaohua LU
1
;
Cheng GUO
2
Author Information
1. Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
2. Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.gboss@126.com
- Keywords:
coronary heart disease;
acute coronary syndrome;
thrombocytopenia;
antithrombotic therapy;
antiplatelet therapy;
anticoagulation treatment
- From:
Journal of Pharmaceutical Practice
2020;38(1):77-80
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the factors and the corresponding treatments for patients with coronary heart disease (CHD) complicated by thrombocytopenia, and provide medical advises for clinical treatment. Methods Literatures and case reports were analyzed and summarized. Results Thrombocytopenia in patient with CHD could be mainly divided into two types, one group was induced by the antithrombotic therapies for CHD, and the other group was caused by some concurrent diseases or combined non-antithrombotic medications. There were different medical decisions and prognoses according to the causes in different groups. Conclusion The treatment strategies of CHD will be considered in the CHD patients with thrombocytopenia. Identifying thrombocytopenia by monitoring the platelet counts in early stage, finding out the causes quickly and providing proper treatments are the key for the prognosis of the patients.
